BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15893306)

  • 1. Dynamic mitochondrial localization of nuclear transcription factor HMGA1.
    Dement GA; Treff NR; Magnuson NS; Franceschi V; Reeves R
    Exp Cell Res; 2005 Jul; 307(2):388-401. PubMed ID: 15893306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-mobility group A1 proteins inhibit expression of nucleotide excision repair factor xeroderma pigmentosum group A.
    Adair JE; Maloney SC; Dement GA; Wertzler KJ; Smerdon MJ; Reeves R
    Cancer Res; 2007 Jul; 67(13):6044-52. PubMed ID: 17616660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
    Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
    Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear HMGA1 nonhistone chromatin proteins directly influence mitochondrial transcription, maintenance, and function.
    Dement GA; Maloney SC; Reeves R
    Exp Cell Res; 2007 Jan; 313(1):77-87. PubMed ID: 17045586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA1 inhibits the function of p53 family members in thyroid cancer cells.
    Frasca F; Rustighi A; Malaguarnera R; Altamura S; Vigneri P; Del Sal G; Giancotti V; Pezzino V; Vigneri R; Manfioletti G
    Cancer Res; 2006 Mar; 66(6):2980-9. PubMed ID: 16540646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative HMGA1 blocks mu enhancer activation through a novel mechanism.
    Andreucci A; Reeves R; McCarthy KM; Nikolajczyk BS
    Biochem Biophys Res Commun; 2002 Mar; 292(2):427-33. PubMed ID: 11906180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Yin Yang-1 (YY1) protein undergoes a DNA-replication-associated switch in localization from the cytoplasm to the nucleus at the onset of S phase.
    Palko L; Bass HW; Beyrouthy MJ; Hurt MM
    J Cell Sci; 2004 Jan; 117(Pt 3):465-76. PubMed ID: 14702388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.
    Cleynen I; Huysmans C; Sasazuki T; Shirasawa S; Van de Ven W; Peeters K
    Cancer Res; 2007 May; 67(10):4620-9. PubMed ID: 17510387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mitochondrial transcription factor A possesses multiple subcellular targeting signals.
    Pastukh V; Shokolenko I; Wang B; Wilson G; Alexeyev M
    FEBS J; 2007 Dec; 274(24):6488-99. PubMed ID: 18028422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
    Akhter MZ; Sharma A; Rajeswari MR
    Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mitochondrial transcription factor A functions in both nuclei and mitochondria and regulates cancer cell growth.
    Han B; Izumi H; Yasuniwa Y; Akiyama M; Yamaguchi T; Fujimoto N; Matsumoto T; Wu B; Tanimoto A; Sasaguri Y; Kohno K
    Biochem Biophys Res Commun; 2011 Apr; 408(1):45-51. PubMed ID: 21453679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential.
    Edberg DD; Bruce JE; Siems WF; Reeves R
    Biochemistry; 2004 Sep; 43(36):11500-15. PubMed ID: 15350136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial biogenesis in mtDNA-depleted cells involves a Ca2+-dependent pathway and a reduced mitochondrial protein import.
    Mercy L; Pauw Ad; Payen L; Tejerina S; Houbion A; Demazy C; Raes M; Renard P; Arnould T
    FEBS J; 2005 Oct; 272(19):5031-55. PubMed ID: 16176275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.
    Baldassarre G; Belletti B; Battista S; Nicoloso MS; Pentimalli F; Fedele M; Croce CM; Fusco A
    Oncogene; 2005 Oct; 24(45):6809-19. PubMed ID: 16007157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional domains of the TGF-beta-inducible transcription factor Tieg3 and detection of two putative nuclear localization signals within the zinc finger DNA-binding domain.
    Spittau B; Wang Z; Boinska D; Krieglstein K
    J Cell Biochem; 2007 Jun; 101(3):712-22. PubMed ID: 17252542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
    Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
    J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protooncogene product, PEBP2beta/CBFbeta, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures.
    Tanaka Y; Watanabe T; Chiba N; Niki M; Kuroiwa Y; Nishihira T; Satomi S; Ito Y; Satake M
    Oncogene; 1997 Aug; 15(6):677-83. PubMed ID: 9264408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.